Z79.811

Billable

Long term (current) use of aromatase inhibitors

Long term (current) use of aromatase inhibitors

Status

Billable / Specific

Block

Z77-Z99

Parent Code

Z79.81

Coding Notes

Inclusion Terms

Alternative clinical terms for this condition

  • Long term (current) use of anastrozole (Arimidex)
  • Long term (current) use of exemestane (Aromasin)
  • Long term (current) use of letrozole (Femara)

Includes

Conditions included under this code

  • long term (current) drug use for prophylactic purposes

Excludes 1

Codes that cannot be used together with this code (mutual exclusion)

Code First

The underlying condition must be sequenced before this code

Code Also

A second code may be required; sequencing depends on circumstances

Related Codes(2)
Also Known As / Clinical Terms(12)

Clinical Terms

  • Long-term current use of aromatase inhibitor
  • Long term (current) use of letrozole (Femara)
  • Long term (current) use of anastrozole (Arimidex)
  • Long-term current use of aromatase inhibitor (situation)
  • Long term (current) use of exemestane (Aromasin)
Frequently Asked Questions
What is the ICD-10 code for long term (current) use of aromatase inhibitors?

The ICD-10-CM code for long term (current) use of aromatase inhibitors is Z79.811. The full clinical description is "Long term (current) use of aromatase inhibitors". Z79.811 is a billable/specific code that can be used on insurance claims and medical billing.

What does ICD-10 code Z79.811 mean?

ICD-10-CM code Z79.811 represents “Long term (current) use of aromatase inhibitors”. It is classified under Chapter 22: Factors Influencing Health Status and Contact With Health Services and is a billable/specific code that can be used on a claim.

Is Z79.811 a billable code?

Yes, Z79.811 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

What chapter is Z79.811 in?

Z79.811 is in Chapter 22: Factors Influencing Health Status and Contact With Health Services (codes Z00-Z99).

What codes cannot be used with Z79.811?

Z79.811 has Excludes1 notes indicating codes that cannot be used together with it, including: hormone replacement therapy (Z79.890).

Are additional codes required with Z79.811?

Yes, when using Z79.811, also report: code, if applicable, to identify:; estrogen receptor positive status (Z17.0); family history of breast cancer (Z80.3); genetic susceptibility to malignant neoplasm (cancer) (Z15.0-); personal history of breast cancer (Z85.3); personal history of prostate cancer (Z85.46); postmenopausal status (Z78.0).

What SNOMED CT codes does Z79.811 map to?

Z79.811 maps to 1 SNOMED CT concept: 449351000124100. SNOMED CT is a clinical terminology used in electronic health records.

What are the UMLS CUIs for Z79.811?

Z79.811 is linked to 4 UMLS Concept Unique Identifiers: C2911194, C2911197, C2911195, C2911196. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

How does Z79.811 relate to ICF functioning codes?

ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like long term (current) use of aromatase inhibitors affect a person's functioning: body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.

What is the ICD-11 equivalent of Z79.811?

There is no direct ICD-11 mapping available for Z79.811 in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.

Automate ICD-10 Coding With AI

Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.

Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.